Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Torii

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Torii's Japan sales performance.

Myovant preps US filing for relugolix in prostate cancer

Myovant preps US filing for relugolix in prostate cancer of 2020 and in Europe and Japan a little later, says the biotech.

FDA advisors say no to empagliflozin in type 1 diabetes

FDA advisors say no to empagliflozin in type 1 diabetes Europe as well as Japan.

Pharmaceutical innovation in the APAC region

Pharmaceutical innovation in the APAC region We examined these factors for Mainland China, Japan and South Korea, concluding, very broadly:. ... Cancer will remain a growth market, although Japan is currently experiencing price containment pressures that other countries will also ultimately face.

Sandoz expands into Japan with €400m Aspen deal

Sandoz expands into Japan with €400m Aspen deal The acquisition will include shares in Aspen Japan K.K. and all associated assets held by AGI. ... Japan’s generic medicines market is the third largest globally, a fact which will aid Sandoz’ continuing growth – in Novartis’ recent third

Daiichi files lawsuit with Seattle over ADCs, including AZ-partnered DS-8201

Daiichi files lawsuit with Seattle over ADCs, including AZ-partnered DS-8201 Dispute covers multiple drugs in Daiichi's antibody-drug conjugates pipeline. A partnership between Seattle Genetics and Japan’s Daiichi Sankyo on antibody-drug conjugates, which ended in 2015, has sparked

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics